• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

针对呼吸道流感病毒感染的免疫预防策略。

Immunoprophylactic strategies against respiratory influenza virus infection.

作者信息

Saravolac E G, Sabuda D, Crist C, Blasetti K, Schnell G, Yang H, Kende M, Levy H B, Wong J P

机构信息

Chemical and Biological Defence Section, Defence Research Establishment Suffield, Box 4000 Station Main, Alberta, T1A 8K6, Medicine Hat, Canada.

出版信息

Vaccine. 2001 Mar 21;19(17-19):2227-32. doi: 10.1016/s0264-410x(00)00450-3.

DOI:10.1016/s0264-410x(00)00450-3
PMID:11257338
Abstract

The objective of this report is to evaluate the prophylactic efficacy of liposome-mediated immunotherapy for prevention of respiratory influenza virus infection in mice. Antiviral antibody, interferon-gamma and poly (ICLC) were encapsulated in liposomes and they were evaluated for their ability to induce protective immunity against lethal influenza infection. Passive immunization using liposome-encapsulated antiviral antibody was found to offer complete protection against the virus challenge. However, this pretreatment must be administered within 24 h prior to virus challenge to be protective. Pretreatment with liposome-encapsulated interferon-gamma was found to stimulate cellular immune responses, but the protection is partial. Immunoprophylaxis using liposome-encapsulated double-stranded (ds) RNA poly (ICLC) provided complete and longer-lasting protection against influenza infection. These results suggest liposome-mediated immunoprophylactic approaches are effective in the prevention of respiratory influenza virus infection.

摘要

本报告的目的是评估脂质体介导的免疫疗法对预防小鼠呼吸道流感病毒感染的预防效果。抗病毒抗体、γ干扰素和聚肌胞苷酸(聚肌苷酸-聚胞嘧啶核苷酸)被包裹在脂质体中,并对它们诱导针对致死性流感感染的保护性免疫的能力进行了评估。发现使用脂质体包裹的抗病毒抗体进行被动免疫可提供针对病毒攻击的完全保护。然而,这种预处理必须在病毒攻击前24小时内进行才能起到保护作用。发现用脂质体包裹的γ干扰素进行预处理可刺激细胞免疫反应,但保护作用是部分的。使用脂质体包裹的双链(ds)RNA聚肌胞苷酸(聚肌苷酸-聚胞嘧啶核苷酸)进行免疫预防可提供针对流感感染的完全且持久的保护。这些结果表明脂质体介导的免疫预防方法在预防呼吸道流感病毒感染方面是有效的。

相似文献

1
Immunoprophylactic strategies against respiratory influenza virus infection.针对呼吸道流感病毒感染的免疫预防策略。
Vaccine. 2001 Mar 21;19(17-19):2227-32. doi: 10.1016/s0264-410x(00)00450-3.
2
Liposome-mediated immunotherapy against respiratory influenza virus infection using double-stranded RNA poly ICLC.使用双链RNA聚肌胞苷酸通过脂质体介导的针对呼吸道流感病毒感染的免疫疗法。
Vaccine. 1999 Mar 26;17(13-14):1788-95. doi: 10.1016/s0264-410x(98)00439-3.
3
Activation of toll-like receptor signaling pathway for protection against influenza virus infection.激活Toll样受体信号通路以预防流感病毒感染。
Vaccine. 2009 May 26;27(25-26):3481-3. doi: 10.1016/j.vaccine.2009.01.048. Epub 2009 Feb 5.
4
Enhanced protection against respiratory influenza A infection in mice by liposome-encapsulated antibody.脂质体包裹抗体增强小鼠对甲型流感病毒感染的防护作用
Immunology. 1994 Feb;81(2):280-4.
5
Intranasal immunization with liposome-encapsulated plasmid DNA encoding influenza virus hemagglutinin elicits mucosal, cellular and humoral immune responses.用脂质体包裹的编码流感病毒血凝素的质粒DNA进行鼻内免疫可引发黏膜、细胞和体液免疫反应。
J Clin Virol. 2004 Dec;31 Suppl 1:S99-106. doi: 10.1016/j.jcv.2004.09.013.
6
Prophylaxis of acute respiratory virus infections using nucleic acid-based drugs.使用基于核酸的药物预防急性呼吸道病毒感染。
Vaccine. 2005 Mar 18;23(17-18):2266-8. doi: 10.1016/j.vaccine.2005.01.037.
7
Nasal vaccination with r4M2e.HSP70c antigen encapsulated into N-trimethyl chitosan (TMC) nanoparticulate systems: Preparation and immunogenicity in a mouse model.鼻腔接种 r4M2e.HSP70c 抗原包被的 N-三甲基壳聚糖(TMC)纳米颗粒系统:在小鼠模型中的制备和免疫原性。
Vaccine. 2018 May 11;36(20):2886-2895. doi: 10.1016/j.vaccine.2018.02.072. Epub 2018 Apr 5.
8
Oral vaccination with a liposome-encapsulated influenza DNA vaccine protects mice against respiratory challenge infection.口服脂质体包裹的流感 DNA 疫苗可保护小鼠免受呼吸道挑战感染。
J Med Virol. 2014 May;86(5):886-94. doi: 10.1002/jmv.23768. Epub 2013 Sep 30.
9
Cross-protection against influenza virus infection by intranasal administration of M1-based vaccine with chitosan as an adjuvant.壳聚糖作为佐剂经鼻腔给予 M1 基疫苗对流感病毒感染的交叉保护作用。
Vaccine. 2010 Nov 10;28(48):7690-8. doi: 10.1016/j.vaccine.2010.09.019. Epub 2010 Sep 24.
10
Consecutive inoculations of influenza virus vaccine and poly(I:C) protects mice against homologous and heterologous virus challenge.连续接种流感病毒疫苗和聚肌胞苷酸可保护小鼠免受同源和异源病毒攻击。
Vaccine. 2017 Feb 15;35(7):1001-1007. doi: 10.1016/j.vaccine.2017.01.025. Epub 2017 Jan 19.

引用本文的文献

1
Activation of the innate immune system provides broad-spectrum protection against influenza A viruses with pandemic potential in mice.先天免疫系统的激活为小鼠提供了针对具有大流行潜力的甲型流感病毒的广谱保护。
Virology. 2010 Oct 10;406(1):80-7. doi: 10.1016/j.virol.2010.07.008. Epub 2010 Jul 27.
2
Pandemic influenza vaccines.大流行性流感疫苗
Curr Top Microbiol Immunol. 2009;333:291-321. doi: 10.1007/978-3-540-92165-3_15.
3
Toll-like receptor 3 ligand and retinoic acid enhance germinal center formation and increase the tetanus toxoid vaccine response.
Toll样受体3配体和视黄酸可增强生发中心的形成并提高破伤风类毒素疫苗的反应。
Clin Vaccine Immunol. 2009 Oct;16(10):1476-84. doi: 10.1128/CVI.00282-09. Epub 2009 Aug 19.
4
Drug delivery-mediated control of RNA immunostimulation.药物递送介导的RNA免疫刺激调控
Mol Ther. 2009 Sep;17(9):1555-62. doi: 10.1038/mt.2009.147. Epub 2009 Jul 7.
5
Antiviral agents active against influenza A viruses.对甲型流感病毒有效的抗病毒药物。
Nat Rev Drug Discov. 2006 Dec;5(12):1015-25. doi: 10.1038/nrd2175.
6
The anti-tetanus immune response of neonatal mice is augmented by retinoic acid combined with polyriboinosinic:polyribocytidylic acid.视黄酸与聚肌苷酸:聚胞苷酸联合使用可增强新生小鼠的抗破伤风免疫反应。
Proc Natl Acad Sci U S A. 2005 Sep 20;102(38):13556-61. doi: 10.1073/pnas.0506438102. Epub 2005 Sep 12.
7
Retinoic acid and polyriboinosinic:polyribocytidylic acid stimulate robust anti-tetanus antibody production while differentially regulating type 1/type 2 cytokines and lymphocyte populations.视黄酸和聚肌苷酸:聚胞苷酸可刺激产生强大的抗破伤风抗体,同时对1型/2型细胞因子和淋巴细胞群体进行不同程度的调节。
J Immunol. 2005 Jun 15;174(12):7961-9. doi: 10.4049/jimmunol.174.12.7961.